Day 3

Today I got to get more hands on in the lab. The first thing that I got to do was go into the tissue culture lab which is a room full of incubators keeping cancer cells alive at normal body temperatures. One of the MDs explained that after extracting cancer cells from a patient in the OR, they are taken to the tissue lab where they are incubated and cultured for growth. Upon growth, they are injected into the lab mice where active cancer growth is observed to be treated with different types of test drugs using computational biology. I got to observe colorectal cancer cells under a microscope while assorting them in different petri dishes under the fume hood. The second thing that I got to do in the lab today was extract DNA from the collected cancer cells. It was interesting to note that extracting the DNA was not at all an arduous task. And yesterday, when I got to observe one of the MDs deal with buffer solutions, I realized that this was the aftermath to what I got to do today. Essentially, to discover the proteins in the RNA of the cancer lines, they first extract the DNA from the cancer cell lines which is converted into RNA, then placed in a buffer solution where, in a two day process, we can determine the existing proteins and pick different drugs to test on these proteins to see which drug weakens them most. But after extracting the DNA and using the incubator to cultivate it, I got to put it on a small slide and observe its architecture under a microscope. It was interesting to see the stark differences but also the subtle similarities between the different cancer cells under the microscope. I got to observe some cancer cells that had been in the incubator for weeks and were flourishing while I also got to observe fresh cancer cells, not yet grown. I also got to observe colorectal cancer cells and kidney cancer cells and noted the differences between those two as well.

Today I also got to take a paraffin block containing cancer cell tissue, slice it, soak it, and put it in a slide for analysis. What I got to do was dye the sliced piece of cancer tissue so that its architecture and makeup is observable under a microscope. And then it can be delivered to the tissue culture lab to be kept in an incubator so that we can visibly see its makeup and whether it is primarily comprised of organoids or fibroblasts. What Dr. Hsu came in and explained to me was that fibroblasts often grow in cancer cell tissue and overtake the organoids inhibiting their growth. This is a big problem when it comes to developing cancer cell lines because the cancer cell lines aren’t pure enough to evaluate for research, and even when they try and purify the lines to allow more pure cancer cells to grow, the fibroblasts still invade the organoids and often make it difficult to see the organoids. What’s nice though is that the makeup of organoids vs. fibroblasts are very different. Fibroblasts are long, weed-like organisms whereas organoids look like clumps of cells. It’s very difficult to get a pure cancer cell line of organoids, so Dr. Hsu has assigned Sarah and I the task of constructing pure organoid cancer cell lines. It’s difficult because as soon as you cut up the cancer tissue and attempt to grow it in separate petri dishes, we create a comfortable environment for the fibroblasts to grow also. So starting today we began to work in the tissue lab to design a procedure to properly construct organoid cancer cell lines without fibroblasts getting in the way. What Dr. Hsu did explain to me though is that the reason why not much research has been diverted to being able to construct these organoid cancer cells without the fibroblasts is that since fibroblasts grow with the growth of cancer cell lines when injected into mice, this in fact helps research how to treat the cancer considering the growth of other cells also. Fibroblasts are key in determining what types of drugs are potent enough to defeat cancer cells because they grow inside of the human body also.

Day 2

So today I actually got to go to the lab and do some research along two MDs and one undergraduate from Duke. Today was mainly an observing day to get a feel for the lab and all of the protocols. I observed the two MD students conduct research while I sat with the undergraduate student (Sarah) who explained to me her data analysis on the potency of different types of drugs on colorectal cancer.  One of the MD students that I was working with showed me some of his work with pipetting tumor cells to be tested for what types of proteins are in them. He explained to me that they transfer tumor cells directly from the OR to the lab to create buffer solutions and test them for what proteins they have inside of them in order to assign different drugs to each solution to test which drug is most effective at dismantling the proteins existing in those solutions. This was particularly interesting especially after learning about buffer solutions in chemistry; seeing one of the MDs put my chemistry knowledge to use was spectacular. I actually got a feel for what I was learning out of a textbook– it was the tangible aspect of all the calculations that I did throughout this year. It’s so fascinating to me that the other side of what seems intangible, almost theoretical numbers are physical appliances with very visible applications.  The other MD took me around the lab for a tour to show me its basic functions and the equipment used to conduct respective experiments. But they also explained to me that most of their research isn’t actual, tangible lab work. Rather, most of their time is spent analyzing the data that they collect evaluating cancer drugs and different mechanisms to approach cancer cures. Again, my chemistry and math knowledge was laid out on a practical level as I observed the MDs and the undergraduate (Sarah) calculate standard deviation when determining the potency of each drug; such practical application with data analysis reminded me a lot of pharmaceutical work, so it was interesting to draw a similarity between those two professions. In general, today was a pretty hands off day, but in the next few days, I’ll be observing drug effects on actual cancer patients that have come through the office, and I’ll be actually going into the clinic and meeting cancer patients with Dr. Hsu.

 

 

Day 1

Today, since Dr. Hsu had to work in the clinic with patients, I did research about what Dr. Hsu actually does on a daily basis. Dr. Hsu pursued an MD PhD so that he could practice medicine with cancer patients while still conducting research in a lab. He explained that 70% of the time he conducts research, writes thesis papers, collaborates with other oncologists while he spends the other 30% of his time working at the Duke Medical Center with cancer patients suffering from gastrointestinal cancers. Most of his clinical work deals with patients with colorectal cancer, and most of his research is conducted on mice where he explores genomics and computational biology. His lab focuses on the use of genomic based technologies to identity and develop novel therapeutic targets for the treatment of gastrointestinal cancers. His lab also develops preclinical models using patient derived xenographs and early passage cell lines in GI cancers. Dr. Hsu has in fact developed this technique further so that it has been used to treat lung, breast, renal, bladder, melanoma, sarcoma, and other cancers. His primary focus however, is on colorectal cancers. He has done a lot of work with drug effects on cancer cell lines exploring the most potent drugs to combat the growth of these cell lines, and the way that he does this is by observing and analyzing cancer growth in mice. And though most of his work consists of working hands on with mice and live cancer cells from the OR, he spends some of his time conducting data analysis to evaluate the potency of certain drugs on different types of cancers.

Wednesday, May 31st – Research, Research, and more Research

As I walked to my desk today, and opened my laptop I was greeted with a long email full of task. Most of my day was spent researching, and learning more about North Carolina. I took away from today that there is a lot going on around me, and I learned about St. Augustine Universities track and field team, and the advancement of STEM. The main takeaway I got from the research is how to write. Often this year we wrote analytically, so it was different to write as a journalist. With the assistance of Mrs. Holt-Noel she communicated the importance of consist writing especially on social media. Next, I learned more about the business side of the job. I got to understand the logistics of organizing rerun shows, and when they air. There is so much more to learn, so that means a lot more research!

-Kennedy Byrd

Skip to toolbar